Key Takeaways include:
- Regulatory expectations for therapies approaching approval and how manufacturing strategies influence regulator confidence.
- Practical insights into how developers can reduce risk and build manufacturing models that support long-term commercial success from case studies of previously approved cell therapies and established modalities like biologics.
Bioscience News and Publications
